PUBLIC LAW 107–172—MAY 14, 2002 116 STAT. 541

Public Law 107–172

107th Congress

An Act

To amend the Public Health Service Act to provide for research, information, and

education with respect to blood cancer.

Be it enacted by the Senate and House of Representatives of

the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the ‘‘Hematological Cancer Research

Investment and Education Act of 2002’’.

SEC. 2. FINDINGS.

Congress finds that:

(1) An estimated 109,500 people in the United States will

be diagnosed with leukemia, lymphoma, and multiple myeloma

in 2001.

(2) New cases of the blood cancers described in paragraph

(1) account for 8.6 percent of new cancer cases.

(3) Those devastating blood cancers will cause the deaths

of an estimated 60,300 persons in the United States in 2001.

Every 9 minutes, a person in the United States dies from

leukemia, lymphoma, or multiple myeloma.

(4) While less than 5 percent of Federal funds for cancer

research are spent on those blood cancers, those blood cancers

cause 11 percent of all cancer deaths in the United States.

(5) Increased Federal support of research into leukemia,

lymphoma, and multiple myeloma has resulted and will continue to result in significant advances in the treatment, and

ultimately the cure, of those blood cancers as well as other

cancers.

SEC. 3. RESEARCH, INFORMATION, AND EDUCATION WITH RESPECT

TO BLOOD CANCER.

Part C of title IV of the Public Health Service Act (42 U.S.C.

285 et seq.) is amended by inserting after section 419C the following:

‘‘SEC. 417D. RESEARCH, INFORMATION, AND EDUCATION WITH RESPECT TO BLOOD CANCER.

‘‘(a) JOE MOAKLEY RESEARCH EXCELLENCE PROGRAM.—

‘‘(1) IN GENERAL.—The Director of NIH shall expand, intensify, and coordinate programs for the conduct and support

of research with respect to blood cancer, and particularly with

respect to leukemia, lymphoma, and multiple myeloma.

‘‘(2) ADMINISTRATION.—The Director of NIH shall carry out

this subsection through the Director of the National Cancer

Institute and in collaboration with any other agencies that

the Director determines to be appropriate.

42 USC 285a–10.

42 USC 285a–10

note

42 USC 201 note.

Hematological

Cancer Research

Investment and

Education Act of

2002.

May 14, 2002

[S. 1094]

116 STAT. 542 PUBLIC LAW 107–172—MAY 14, 2002

LEGISLATIVE HISTORY—S. 1094:

CONGRESSIONAL RECORD, Vol. 147 (2001):

Nov. 16, considered and passed Senate.

Apr. 30, considered and passed House.

Æ

‘‘(3) AUTHORIZATION OF APPROPRIATIONS.—For the purpose

of carrying out this subsection, there is authorized to be appropriated such sums as may be necessary for fiscal year 2002

and each subsequent fiscal year. Such authorizations of appropriations are in addition to other authorizations of appropriations that are available for such purpose.

‘‘(b) GERALDINE FERRARO CANCER EDUCATION PROGRAM.— ‘‘(1) IN GENERAL.—The Secretary shall direct the appropriate agency within the Department of Health and Human

Services, in collaboration with the Director of NIH, to establish

and carry out a program to provide information and education

for patients and the general public with respect to blood cancer,

and particularly with respect to the treatment of leukemia,

lymphoma, and multiple myeloma. ‘‘(2) ADMINISTRATION.—The Agency determined by the Secretary under paragraph (1) shall carry out this subsection in

collaboration with private health organizations that have

national education and patient assistance programs on bloodrelated cancers. ‘‘(3) AUTHORIZATION OF APPROPRIATIONS.—For the purpose

of carrying out this subsection, there is authorized to be appropriated such sums as may be necessary for fiscal year 2002

and each subsequent fiscal year. Such authorizations of appropriations are in addition to other authorizations of appropriations that are available for such purpose.’’.

Approved May 14, 2002.